Integration of clinical and cellular lipidomics identifies a serum metabolite signature predictive of oxaliplatin resistance in colorectal cancer.
Journal:
Functional & integrative genomics
Published Date:
Apr 14, 2026
Abstract
No abstract available for this article.
Authors
Keywords
No keywords available for this article.
